Treatment-Related Adverse Effects in Lung Cancer Patients after Stereotactic Ablative Radiation Therapy.

J Oncol · 2018 · PMC6193322 · PMID 30402100

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

[ 21 ] with 70 stage I and II NSCLC patients with central and peripheral tumours, treated with 60 Gy in 3 fractions or 66 Gy in 3 fractions, found that while toxicity rates in central tumour patients (27.3%) were higher than the rates of toxicity in peripheral tumour patients (10.4%), the result did not reach statistical significance.

also in 111,027 other papers

a strong trendno p-value reported

There was also a strong trend towards studies investigating SABR for peripheral lung lesions, with, what appeared to be, studies avoiding SABR for central lung cancer lesions.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.